Can angiogenesis be exploited to improve stroke outcome? Mechanisms and therapeutic potential

Clinical Science

Volumn 111, Issue 3, 2006, Pages 171-183

  Slevin, Mark ^a   Kumar, Pat ^a   Gaffney, John ^a   Kumar, Shant ^b   Krupinski, Jerzy ^c,d  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

Angiogenesis; Angiogenic factor; Endothelial cell; Ischaemic stroke; Neurogenesis; Penumbra

Indexed keywords

ANGIOGENESIS; CIRCULATION; CONVALESCENCE; NERVE CELL; PERFUSION; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; STROKE; TREATMENT OUTCOME;

ANGIOGENESIS INDUCING AGENTS; CEREBROVASCULAR ACCIDENT; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; NEURONAL PLASTICITY; SIGNAL TRANSDUCTION; STROKE;

EID: 33748463817     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20060049     Document Type: Review

References (138)

1. Folkman, J. (1971) Tumour angiogenesis: therapeutic implications. N. Eng. J. Med. 285, 1182-1186
2. Krupinski, J., Kaluza, J., Kumar, P., Wang, M. and Kumar, S. (1993) Prognostic value of blood vessel density in ischemic stroke. Lancet 342, 742
3. Krupinski, J., Kaluza, J., Kumar, P., Kumar, S. and Wang, J. M. (1994) Role of angiogenesis in patients with cerebral ischaemic stroke. Stroke 25, 1794-1798
4. Krupinski, J., Stroemer, P., Slevin, M., Marti, E., Kumar, P. and Rubio, F. (2003) Three dimensional structure of newly formed blood vessels after focal cerebral ischaemia in rat. NeuroReport 14, 1171-1176
5. Segura, I., Serrano, A., De Buitrago, G. G. et al. (2002) Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis. FASEB J. 8, 833-841
6. Wei, L., Erinjeri, J. P., Rovainen, C. M. and Woolsey, T. A. (2001) Collateral growth and angiogenesis around cortical growth. Stroke 32, 2179-2184
7. Gu, W., Brannstrom, T., Jiang, W., Bergh, A. and Wester, P. (2001) Vascular endothelial growth factor-A and -C protein up-regulation and early angiogenesis in a rat photothrombic ring stroke model with spontaneous reperfusion. Acta. Neuropathol. 102, 216-226
8. Heiss, W. D., Sobesky, J. and Hesselmann, V. (2004) Identifying thresholds for penumbra and irreversible tissue damage. Stroke 35, 2671-2674
9. Maulaz, A., Piechowski-Jozwiak, B., Michel, P. and Bogousslavsky, J. (2005) Selecting patients for early stroke treatment with penumbra images. Cerebrovasc. Dis. 20, 19-24
10. Butcher, K. S., Parsons, M., MacGregor, L. et al. (2005) Refining the perfusion-diffusion mismatch hypothesis. Stroke 36, 1153-1159
11. Rivers, C. S., Wardlaw, J. M., Armitage, P. A. et al. (2006) Do acute diffusion- and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke? Stroke 37, 98-104
12. Albers, G. W. (1999) Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. Stroke 30, 2230-2237
13. Chen, H. H., Chien, C. H. and Liu, H. M. (1994) Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct. Stroke 25, 1651-1657
14. Jiang, Q., Zhang, Z. G., Ding, G. L. et al. (2005) Investigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using MRI. NeuroImage 28, 698-707
15. Ward, N. S. (2005) Neural plasticity and recovery of function. Prog. Brain Res. 150, 527-535
16. Slevin, M., Krupinski, J., Kumar, P., Gaffney, J. and Kumar, P. (2005) Gene activation and protein expression following ischaemic stroke: strategies towards neuroprotection. J. Cell. Mol. Med. 9, 85-102
17. Krupinski, J., Kumar, P., Kumar, S. and Kaluza, J. (1996) Increased expression of TGF-β1 in brain tissue after ischaemic stroke in humans. Stroke 27, 852-857
18. Krupinski, J., Issa, R., Bujny, T., Slevin, M., Kumar, P., Kumar, S. and Kaluza, J. (1997) A putative role for platelet derived growth factor in angiogenesis and neuroprotection after ischaemic stroke in humans. Stroke 28, 564-573
19. Issa, R., Krupinski, J., Bujny, T., Kumar, S., Kaluza, P. and Kumar, P. (1999) Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischaemic stroke. Lab. Invest. 79, 417-425
20. Slevin, M., Krupinski, J., Slowik, A., Kumar, P., Szczudlik, A. and Gaffney, J. (2000) Serial measurement of vascular endothelial growth factor and transforming growth factor β1 in serum of patients with acute ischaemic stroke. Stroke 31, 1863-1870
21. Issa, R., AlQteishat, A., Mitsios, N. et al. (2005) Expression of basic fibroblast growth factor mRNA and protein in the human brain following ischaemic stroke. Angiogenesis 8, 53-62
22. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S. and Dvorak, H. F. (1983) Tumour cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-985
23. Leung, D. W., Cachianes, G., Goeddel, D. V. and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-1309
24. Ferrara, N. and Henzel, W. J. (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161, 851-858
25. Tammela, T., Enholm, B., Alitalo, K. and Paavonen, K. (2005) The biology of vascular endothelial growth factors. Cardiovasc. Res. 65, 550-563
26. Ferrara, N. (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr. Rev. 25, 581-611
27. Marti, H. J., Bernaudin, M., Bellail, A. et al. (2000) Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischaemia. Am. J. Pathol. 156, 965-976
28. Sun, Y., Jin, K., Xie, L. et al. (2003) VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischaemia. J. Clin. Invest. 111, 1843-1851
29. Ding, Y. H., Luan, X. D., Li, J. et al. (2004) Exercise-induced overexpression of angiogenesis factors and reduction of ischaemia/reperfusion injury in stroke. Curr. Neurovasc. Res. 1, 411-420
30. Stiver, S. I., Tan, X., Brown, L. F., Hedley-White, E. T. and Dvorak, H. F. (2004) VEGF-A angiogenesis induces a stable neovasculature in adult murine brain. J. Neuropath. Exp. Neurol. 63, 841-845
31. Yano, A., Shingo, T., Takeuchi, A. et al. (2005) Encapsulated vascular endothelial growth factor-secreting cell grafts have neuroprotective and angiogenic effects on focal cerebral ischaemia. J. Neurosurg. 103, 104-114
32. Weis, S. M. and Cheresh, D. A. (2005) Physiological consequences of VEGF-induced vascular permeability. Nature (London) 437, 497-504
33. Bertolino, P., Deckers, M., Lebrin, F. and ten Dijke, P. (2005) Transforming growth factor-β signal transduction in angiogenesis and vascular disorders. Chest 128, 585-590
34. Guo, B., Slevin, M., Li, C. et al. (2004) CD105 inhibits transforming growth factor-β-smad3 signalling. Anticancer Res. 24, 1337-1345
35. Ata, A. K., Funa, K. and Olsson, Y. (1997) Expression of TGF-β isoforms and type I receptor in necrotizing human brain lesions. Acta. Neuropath. 93, 326-333
36. Zhang, Z., Zhang, L., Jiang, Q. and Chopp, M. (2002) Bone-marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ. Res. 90, 284-288
37. Krupinski, J., Vodovotz, Y., Li, C. et al. (1998) Inducible nitric oxide production and expression of transforming growth factor-β1 in serum and CSF after cerebral ischaemic stroke in man. Nitric Oxide 2, 442-453
38. Sporn, M. B. (2006) The early history of TGF-β, and a brief glimpse of its future. Cytokine Growth Factor Rev. 17, 3-7
39. Vivien, D. and Ali, C. (2006) Transforming growth factor-β signalling in brain disorders. Cytokine Growth Factor Rev. 17, 121-128
40. Anzano, M. A., Roberts, A. B., Smith, J. M., Sporn, M. B. and De Larco, J. E. (1983) Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type α and type β transforming growth factors. Proc. Natl. Acad. Sci. U.S.A. 80, 6264-6268
41. Roberts, A. B., Frolik, C. A., Anzano, M. A. and Sporn, M. B. (1983) Transforming growth factors from neoplastic and non-neoplastic tissues. Fed. Proc. 42, 2621-2626
42. Roberts, A. B., Anzano, M. A., Wakefield, L. M., Roche, N. S. Stern, D. F. and Sporn, M. B. (1985) Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. U.S.A. 82, 119-123
43. Roberts, A. B., Sporn, M. B., Assoian, R. K. et al. (1986) Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. U.S.A. 83, 4167-4171
44. Wahl, S. M. (1994) Transforming growth factor β: the good the bad and the ugly. J. Exp. Med. 180, 1587-1590
45. Prehn, J. H., Backhauss, C. and Krieglstein, J. (1993) Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischaemic injury in vivo. J. Cereb. Blood Flow Metab. 13, 521-525
46. Prehn, J. H., Peruche, B., Unsicker, K. and Krieglstein, J. (1993) Isoform specific effects of transforming growth factors-β on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate. J. Neurochem. 60, 1665-1672
47. Ruocco, A., Nicole, O., Docagne, F. et al. (1999) A transforming growth factor-β antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischaemic brain injury. J. Cereb. Blood Flow Metab. 19, 1345-1353
48. Gospodarowicz, D., Bialecki, H. and Greenburg, G. (1978) Purification of the fibroblast growth factor activity from bovine brain. J. Biol. Chem. 253, 3736-3743
49. Gospodarowicz, D., Cheng, J. and Lirette, M. (1983) Bovine brain and pituitary growth factors: comparison of their abilities to support the proliferation of human and bovine vascular endothelial cells. J. Cell. Biol. 97, 1677-1685
50. Bohlen, P., Esch, F., Baird, A. and Gospodarowicz, D. (1985) Acidic fibroblast growth factor (FGF) from bovine brain amino terminal sequence and comparison with basic FGF. EMBO J. 4, 1951-1956
51. Esch, F., Baird, A., Ling, D. et al. (1985) Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc. Natl. Acad. Sci. U.S.A. 82, 6507-6511
52. Walicke, P., Cowan, W. M., Ueno, N., Baird, A. and Guillemin, R. (1986) Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension. Proc. Natl. Acad. Sci. U.S.A. 83, 3012-3016
53. Walicke, P. (1988) Basic and acidic growth factors have trophic effects on neurons from multiple CNS regions. J. Neurosci. 8, 2618-2627
54. McKinnon, R. D., Matsui, T., Dubois-Dalcq, M. and Aaronson, S. A. (1990) FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5, 603-614
55. Speliotes, E. K., Caday, C. G., Do, T. et al. (1996) Increased expression of basic fibroblast growth factor (bFGF) following focal cerebral infarction in the rat. Brain Res. Mol. Brain Res. 39, 31-42
56. Jiang, N., Finklestein, S. P., Do, T., Caday, C. G., Charette, M. and Chopp, M. (1996) Delayed intravenous administration of basic fibroblast growth factor (bFGF) reduces infarct volume in a model of focal cerebral ischaemia/reperfusion in the rat. J. Neurol. Sci. 139, 173-179
57. Kawamata, T., Speliotes, E. K. and Finklestein, S. P. (1997) The role of polypeptide growth factors in recovery from stroke. Adv. Neurol. 73, 377-382
58. Kawamata, T., Dalton, D. W., Schallert, T., Cocke, J. R., Benowitz, L. I. and Finklestein, S. P. (1997) Intracisternal basic fibroblast growth factor enhances and up-regulates the expression of a molecular marker of sprouting following focal cerebral infarction. Proc. Natl. Acad. Sci. U.S.A. 94, 8179-8184
59. Wada, K., Suigimori, H., Bhide, P. G., Moskowitz, M. A. and Finklestein, S. P. (2003) Effect of basic fibroblast growth factor treatment on brain progenitor cells after permanent focal ischaemia in rats. Stroke 34, 2722-2728
60. Wu, D. (2005) Neuroprotection in experimental stroke with targeted neurotrophins. NeuroRx 2, 120-128
61. Ren, J. M. and and Finklestein, S. P. (2005) Growth factor treatment and stroke. Curr. Drug Targets CNS Neurol. Disord. 4, 121-125
62. Stiles, C. D., Capone, G. T., Scher, C. D., Antoniades, H. N., Van Wyk, J. J. and Pledger, W. J. (1979) Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc. Natl. Acad. Sci. U.S.A. 76, 1279-1283
63. Antoniades, H. N. (1981) Human platelet derived growth factor (PDGF): purification of PDGF-I and PDGF-II and separation of their reduced subunits. Proc. Natl. Acad. Sci. U.S.A. 78, 7314-7317
64. Risau, W., Drexler, H., Mironov, V. et al. (1992) Platelet-derived growth factor is angiogenic in vivo. Growth Factors 7, 261-266
65. Iihara, K., Sasahara, M., Hashimoto, N., Uemura, Y., Kikuchi, H. and Hazama, F. (1994) Ischaemia induces the expression of the platelet-derived growth factor-B chain in neurones and brain macrophages in vivo. J. Cereb. Blood Flow Metab. 14, 818-824
66. Niimi, H. (2003) Cerebral angiogenesis induced by-growth factors: intravital microscopic studies using models. Clin. Hemorheol. Microcirc. 29, 149-156
67. Yamagishi, S. and Imaizumi, T. (2005) Pericyte biology and diseases. Int. J. Tissue React. 27, 125-135
68. Renner, O., Tsimpas, A., Kostin, S., Valable, S., Petit, E., Shaper, W. and Marti, H. H. (2003) Time- and cell type-specific induction of platelet-derived growth factor receptor-beta during cerebral ischaemia. Brain Res. Mol. Brain Res. 113, 44-51
69. Miyate, T., Iizasa, H., Sai, Y., Fujii, J., Terasaki, T. and Nakashima, E. (2005) Platelet-derived growth factor-BB (PDGF-BB) induces differentiation of bone-marrow endothelial progenitor cell-derived cell line TR-BME2 into mural cells, and changes the phenotype. J. Cell. Physiol. 204, 948-955
70. Lehti, K., Allen, E., Birkedal-Hansen, H. et al. (2005) An MT1-MMP-PDGF receptor beta axis regulates mural cell investment of the microvasculature. Genes Dev. 19, 979-991
71. Reigstad, L. J., Varhaug, J. E. and Lillehaug, J. R. (2005) Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family. FEBS J. 272, 5723-5741
72. Berra, E., Pages, G. and Pouyssegur, J. (2000) MAP kinases and hypoxia in the control of gene expression. Cancer Metastasis Rev. 19, 139-145
73. Krupinski, J., Slevin, M., Marti, E., Catena, E., Rubio, F. and Gaffney, J. (2003) Time-course phosphorylation of the MAP kinase group of signalling proteins and related molecules following middle cerebral artery occlusion in the rat. Neuropath. App. Neurobiol. 29, 144-158
74. Slevin, M., Krupinski, J., Slowik, A., Rubio, F., Szczudlik, A. and Gaffney, J. (2000) Activation of MAP kinase (ERK-1/ERK-2) tyrosine kinase and VEGF in the human brain following acute ischaemic stroke. NeuroReport 11, 2759-2764
75. Kirsch, T., Wellner, M., Luft, F. C., Haller, H. and Lippoldt, A. (2001) Altered gene expression in cerebral capillaries of stroke-prone spontaneously hypertensive rats. Brain Res. 910, 106-115
76. Carmichael, S. T. (2003) Gene expression changes after focal stroke, traumatic brain and spinal cord injuries. Curr. Opin. Neurol. 16, 699-704
77. Conway, E. M., Zwerts, F., Van Eygen, V. et al. (2003) Survival-dependent angiogenesis in ischaemic brain: molecular mechanisms of hypoxia-induced up-regulation. Am. J. Pathol. 163, 935-946
78. Hahn, C. N., Su, Z. J., Drogemuller, C. J. et al. (2006) Expression profiling reveals functionally important genes and co-ordinately regulated signalling pathway genes during in vitro angiogenesis. Physiol. Genomics 22, 57-69
79. Sun, X. T., Zhang, M. Y., Shu, C. et al. (2005) Differential gene expression during capillary morphogenesis in a microcarrier based three-dimensional in vitro model of angiogenesis with focus on chemokines and chemokine receptors. World J. Gastroenterol. 11, 2283-2290
80. Kwon, M. and Libutti, S. K., (2006) Advances in understanding angiogenesis through molecular studies. Int. J. Radiat. Oncol. Biol. Phys. 64, 26-32
81. van Beijnum, J. R. and Griffioe, A.W. (2005) In silico analysis of angiogenesis associated gene expression identifies angiogenic stage related profiles. Biochim. Biophys. Acta 1755, 121-134
82. Xu, J., Ahmed, S. H., Chen, S. W., Goldenberg, M. P., Beckman, J. S. and Hsu, C. Y. (2000) Oxygen-glucose deprivation induces inducible nitric oxide synthase and nitrotyrosine expression in cerebral endothelial cells. Stroke 31, 1744-1751
83. Wang, X., Zhou, Y., Kim, H. P. et al. (2004) Hepatocyte growth factor protects against hypoxia/reoxygenation-induced apoptosis in endothelial cells. J. Biol. Chem. 279, 5237-5243
84. Dhar-Mascareno, M., Carcamo, J. M. and Golde, D. W. (2005) Hypoxia-reoxygenation-induced mitochondrial damage and apoptosis in human endothelial cells are inhibited by vitamin C. Free Radical Biol. Med. 38, 1311-1322
85. Scarabelli, T. M., Stephanou, A., Pasini, K. et al. (2002) Different signalling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischaemia/reperfusion injury. Circ. Res. 90. 745-748
86. Lee, S. R. and Lo, E. H. (2003) Interactions between p38 mitogen-activated protein kinase and caspase-3 in cerebral endothelial cell death after hypoxia-reoxygenation. Stroke 34, 2704-2709
87. Alitalo, K., Tammela, T. and Petrova, T. V. (2005) Lymphangiogenesis in development and human disease. Nature (London) 438, 946-953
88. Carmeliet, P. (2005) Angiogenesis in life, disease and medicine. Nature (London) 438, 932-936
89. Ferrara, N. and Kerbel, R. S. (2005) Angiogenesis as a therapeutic target. Nature (London) 438, 967-974
90. Saitoh, Y., Kato, A., Hagihara, Y., Kaneda, Y. and Yoshimine, T. (2003) Gene therapy for ischemic brain diseases. Curr. Gene Ther. 3, 49-58
91. Kusaka, N., Sugiu, K., Tokunaga, K. et al. (2005) Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery. J. Neurosurg. 103, 882-890
92. Bellomo, M., Adamo., E. B., Deodato, B. et al. (2003) Enhancement of expression of vascular endothelial growth factor after adeno-associated virus gene transfer is associated with improvement of brain ischemia injury in the gerbil. Pharmacol. Res. 48, 309-317
93. van Bruggen, N., Thibodeaux, H., Palmer, J. T. et al. (1999) VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J. Clin. Invest. 104, 1613-1620
94. Wang, Y., Kilic, E., Kilic, U. et al. (2005) VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain 128, 52-63
95. Zhu, Y., Lee, C., Shen, F., Du, R., Young, W. L. and Yang, G. Y. (2005) Angiopoietin-2 facilitates vascular endothelial growth factor-induced angiogenesis in the mature mouse brain. Stroke 36, 1533-1537
96. Valable, S., Montaner, J., Bellail, A. et al. (2005) VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1. J. Cereb. Blood. Flow. Metab. 25, 1491-1504
97. Matsuda, T., Abe, T., Wu, J. L., Fujiki, M. and Kobayashi, H. (2005) Hypoxia-inducible factor-1alpha DNA-induced angiogenesis in a rat cerebral ischemia model. Neurol. Res. 27, 503-508
98. Sharp, F. R. and Bernaudin, M. (2004) HIF1 and oxygen sensing in the brain. Nat. Rev. Neurosci. 5, 437-448
99. Heinl-Green, A., Radke, P. W., Munkonge, F. M. et al. (2005) The efficacy of a master switch gene HIF-1α in a porcine model of chronic myocardial ischaemia. Eur. Heart J. 26, 1327-1332
100. Luo, J. and Chen, A. (2005) Nitric oxide: a newly discovered function on wound healing. Acta Pharmacol. Sin. 26, 259-264
101. Freeman, R. S. and Barone, M. C. (2005) Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders. Curr. Drug Targets CNS Neurol. Disord. 4, 85-92
102. Pajusola, K., Kunnapu, J., Vuorikoski, S. et al. (2005) Stabilized HIF-1α is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer. FASEB J. 19, 1365-1367
103. Marti, H. H. (2005) Angiogenesis- a self adapting principle in hypoxia. Experientia 94, 163-180
104. Cuevas, P. and Asin-Cardiel, E. (2000) Electromagnetic therapeutic angiogenesis: the next step. Neurol. Res. 22, 349-350
105. Chen, J., Zhang, C., Jiang, H. et al. (2005) Atorvastatin induction of VEGF and BDNF promotes brain plasticity alter stroke in mice. J. Cereb. Blood Flow Metab. 25, 281-290
106. Zhang, Z. and Chopp, M. (2002) Vascular endothelial growth factor and angiopoietins in focal cerebral ischaemia. Trends Cardiovasc. Med. 12, 62-66
107. Kaya, D., Gursoy-Ozdemir, Y., Yemisci, M., Tuncer, N., Aktan, S. and Dalkara, T. (2005) VEGF protects brain against focal ischemia without increasing blood-brain permeability when administered intracerebroventricularly. J. Cereb. Blood Flow Metab. 25, 1111-1118
108. Hiratuska, S., Nakamura, K., Iwai, S. et al. (2002) MMP-9 induction by vascular endothelial growth factor receptor-1 is involved in lung specific metastasis. Cancer Cell. 2, 289-300
109. Cunningham, L., Wetzel, M. and Rosenberg, G. (2005) Multiple role for MMPs and TIMPs in cerebral ischemia. Glia 50, 329-339
110. Depino, A., Ferrari, C., Pott Godoy, M. C., Tarelli, R. and Pitossi, F. J. (2005) Differential effects of interleukin-1β on neurotoxicity, cytokine induction and glial reaction in specific brain regions. J. Neuroimmunol. 168, 96-110
111. Friedman, W. J. (2005) Interactions of interleukin-1 with neurotrophic factors in the central nervous system: beneficial or detrimental? Mol. Neurobiol. 32, 133-144
112. Charalambous, C., Pen, L. B., Su, Y. S., Milan, J., Chen, T. C. and Hofman, F. M. (2005) Interleukin-8 differentially regulates migration of tumour-associated and normal human brain endothelial cells. Cancer Res. 65, 10347-10354
113. Naldini, A. and Carraro, F. (2005) Role of inflammatory mediators in angiogenesis. Curr. Drug Targets Inflamm. Allergy 4, 3-8
114. Buschmann, I. R., Busch, H. J., Mies, G. and Hossmann, K. A. (2003) Therapeutic induction of arteriogenesis in hypoperfused rat brain via granulocyte-macrophage colony-stimulating factor. Circulation 108, 610-615
115. Jin, K., Zhu, Y., Sun, Y., Mao, X. O., Xie, L. and Greenberg, D. A. (2002) Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 99, 11946-11950
116. Eichmann, A., Makinen, T. and Alitalo, K. (2005) Neural guidance molecules regulate vascular remodelling and vessel navigation. Genes Dev. 19, 1013-1021
117. Shimamura, M., Sato, N., Oshima, K. et al. (2004) Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model. Circulation 109, 424-431
118. Sugiura, S., Kitagawa, K., Tanaka, S. et al. (2005) Adenovirus-mediated gene transfer of heparin-binding epidermal growth factor-like growth factor enhances neurogenesis and angiogenesis after focal cerebral ischemia in rats. Stroke 36, 859-864
119. Wei, L., Keogh, C., Whitaker, V., Theu, M. and Yu, S. (2005) Angiogenesis and stem cell transplantation as potential treatments of cerebral ischemic stroke. Pathophysiology 12, 47-62
120. Wei, L., Wand, J., Hedrick, M. et al. (2005) Vasculogenesis, angiogenesis and local blood flow recovery after embryonic stem cells transplantation in the ischemic brain. J. Cereb. Blood Flow Metab. 25, S524
121. Maiese, K., Li, F. and Chong, Z. (2005) New avenues of exploration for erythropoietin. JAMA, J. Am. Med. Assoc. 293, 90-95
122. Kokovay, E., Li, L. and Cunningham, L. (2006) Angiogenic recruitment of pericytes from bone marrow after stroke. J. Cereb. Blood Flow Metab. 26, 545-555
123. Taguchi, A., Soma, T., Tanaka, H. et al. (2004) Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis m a mouse model. J. Clin. Invest. 114, 330-338
124. Nakatomi, H., Kurui, T., Okabe, S. et al. (2002) Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110, 429-441
125. Drago, J., Murphy, M., Carroll, S. M., Harvey, R. P. and Bartlett, R. P. (1991) Fibroblast growth factor mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I. Proc. Natl. Acad. Sci. U.S.A. 88, 2199-2203
126. Jung, K. H., Chu, K., Lee, S. T. et al. (2006) Granulocyte colony-stimulating factor stimulates neurogenesis via vascular endothelial growth factor with STAT activation. Brain Sci., doi:10.1016/j.brainres.2006.03. 114
127. Manoonkitiwongsa, P. S., Schultz, R. L., McCreery, D. B., Whitter, E. F. and Lyden, P. D. (2004) Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis. J. Cereb. Blood Flow Metab. 24, 693-702
128. Conway, E. M. (2004) Angiogenesis: a link to thrombosis in athero-thrombotic disease. Pathophysiol. Haemostasis Thromb. 33, 241-248
129. Zukowska, Z. (2005) Athersoclerosis and angiogenesis: what do nerves have to do with it? Pharmacol. Rep. 57, 229-234
130. Krupinski, J., Turu, M. M., Martinez-Gonzalez, J. et al. (2006) Endogenous expression of C-reactive protein is increased in active (ulcerated non-complicated) human carotid artery plaques. Stroke 37, 1200-1204
131. McCarthy, M. J., Loftus, I. M., Thompson, M. M. et al. (1999) Angiogenesis and the atheroscleotic carotid plaque: an association between symptomatology and plaque morphology. J. Vasc. Surg. 30, 261-268
132. Waltenberger, J. (2005) Growth factor signal transduction defects in the cardiovascular system. Cardiovasc. Res. 65, 574-580
133. Moulton, K. (2001) Plaque angiogenesis and atherosclerosis. Curr. Atheroscler. Rep. 3, 225-233
134. Factor, P. (2001) Gene therapy for acute diseases. Mol. Ther. 4, 515-524
135. Yenari, M. A., Dumas, T. C., Sapolsky, R. M. and Steinberg, G. K. (2001) Gene therapy for treatment of cerebral ischaemia during defective herpes simplex trials. Neurol. Res. 23, 543-552
136. Ferrara, N and Alitalo, K. (1999) Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5, 1359-1364
137. Simons, M. (2005) Angiogenesis: where do we stand now? Circulation 111, 1556-1566
138. Bhardwaj, S., Roy, H., Gruchala, M. et al. (2003) Angiogenic responses of vascular endothelial growth factors in periadventitial tissue. Hum. Gene. Ther. 14, 1451-1462